The Journal of Korean Physical Therapy

The Korean Society of Physical Therapy (대한물리치료학회)
권호 표지
DOI QR코드

DOI QR Code

The Prevalence of Gout and Its Risk Factors in Healthy Workers

  • Kwon, Gi-Hong (Division of Health and Science, Yeungnam University College) ;
  • Chun, Byung Yeol (Department of Preventive Medicine and Public Health, School of Medicine, Kyungpook National University) ;
  • Kwon, Yong Hyun (Department of Physical Therapy, Yeungnam University College)
  • Received : 2016.09.12
  • Accepted : 2016.10.31
  • Published : 2016.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was conducted to investigate the prevalence and risk of gout in healthy workers. Methods: This cross-sectional analysis was conducted in 1,876 subjects (1,515 men and 361 women) enrolled in the Healthy Worker Cohort Study at Daegu, South Korea. Relationships between serum uric acid levels and independent risk factors were evaluated using multiple linear regression analysis after adjustment for covariates. Results: Among study participants, the prevalence of gout was 22.9% in men and 2.5% in women (based on a serum uric acid level >7.0 mg/dL for men and >6.0 mg/dL for women). Among men, increased ALT, GGT, total cholesterol, and triglycerides were associated with increased risk of gout (p<0.05) by multiple linear regression analysis; however, increased age and HDL-cholesterol/triglyceride ratio were associated with decreased risk of gout (p<0.05). In women, increased triglycerides were associated with increased risk of gout (p<0.05). Conclusion: Our findings suggest that increased triglycerides were significantly associated with the risk of gout in men and women. Moreover, a high HDL-cholesterol/triglyceride ratio in men may reduce the risk of gout.

Keywords

References

  1. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2010;143:499-516.
  2. Kuo CF, Grainge MJ, Mallen C et al. Rising burden of gout in the UK but continuing suboptimal management: a national population study. Annals of the rheumatic disease. 2015;74(4):661-7. https://doi.org/10.1136/annrheumdis-2013-204463
  3. Robinson PC, Taylor WJ, Meriman TR. Systematic review of the prevalence of gout and hyperuricemia in Australia. Internal Medicine journal. 2012;42(9):997-1007. https://doi.org/10.1111/j.1445-5994.2012.02794.x
  4. Winnard D, Wright C, Taylor WJ et al. National prevalence of gout derivative from administer health data Aotearoa NewZealand. Rheumatology (Oxford, England). 2012;51:901-9. https://doi.org/10.1093/rheumatology/ker361
  5. Kuo CF, Grainge MJ, Zhang W et al. Global epidemiology of gout. Prevalence, incidence and risk factors. Nature reviews rheumatology. 2015.
  6. Abbott RD, Brand FN, Kannel WB et al. Gout and coronary heart disease: the Framingham study. J Clin Epidemiol. 1988;41(3):237-42. https://doi.org/10.1016/0895-4356(88)90127-8
  7. Chen SY, Chen CL, Shen ML. Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol. 2007;26(3):308-13. https://doi.org/10.1007/s10067-006-0292-4
  8. Full LE, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2009;11(2):217. https://doi.org/10.1186/ar2631
  9. Krishnan E, Svendsen K, Neaton JD et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008; 168(10):1104-10. https://doi.org/10.1001/archinte.168.10.1104
  10. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894-900. https://doi.org/10.1161/CIRCULATIONAHA.107.703389
  11. Ishizaka N, Ishizaka Y, Toda E et al. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005;25(5): 1038-44. https://doi.org/10.1161/01.ATV.0000161274.87407.26
  12. Ito H, Abe M, Mifune M et al. Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One. 2011;6(11):e27817. https://doi.org/10.1371/journal.pone.0027817
  13. Zhu Y, Pandya BJ, Choi MK. Prevalence and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008. Arthritis and rheumatism. 2011;63(10):3136-41. https://doi.org/10.1002/art.30520
  14. Rathmann W, Funkhouser E, Dyer AR et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary artery risk development in young adults. Ann Epidemiol. 1998;8(4):250-61. https://doi.org/10.1016/S1047-2797(97)00204-4
  15. Choi HK, Ford ES, Li C et al. Prevalence of the metabolic syndrome in patients with gout: the third national health and nutrition examination survey. Arthritis Rheum. 2007;57(1):109-15. https://doi.org/10.1002/art.22466
  16. Rho YH, Choi SJ, Lee YH et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005; 20(6):1029-33. https://doi.org/10.3346/jkms.2005.20.6.1029
  17. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-21. https://doi.org/10.1056/NEJMra0800885
  18. Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol. 2010;22(2):165-72. https://doi.org/10.1097/BOR.0b013e328335ef38
  19. Bae J, Chun BY, Park PS et al. Higher consumption of sugar-sweetened soft drinks increases the risk of hyperuricemia in Korean population: the Korean multi-rural communities cohort study. Semin Arthritis Rheum. 2014;43(5):654-61. https://doi.org/10.1016/j.semarthrit.2013.10.008
  20. Park EH, Park JH, Song JS et al. Two-year follow-up study of the relationship between the changes of serum homocysteine and those of serum uric acid levels. Lipid Profiles and Renal Function in Gout Patients Journal of Rheumatic Diseases. 2016;23(1):30-6.
  21. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404-10. https://doi.org/10.1001/jama.283.18.2404
  22. Wallace KL, Riedel AA, Joseph-Ridge N et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31(8):1582-7.
  23. Lee CH, Sung NY. The prevalence and features of Korean gout patients using the national health insurance corporation database. J Rheum Dis. 2011;18:94-100. https://doi.org/10.4078/jrd.2011.18.2.94
  24. Song JS, Rising Gout. Life threatening public enemy. J Korean Rheum Assoc. 2011;18:234-41.
  25. Lee SJ, Hirsch JD, Terkeltaub R et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(11):582-6.
  26. Choi HK, Atkinson K, Karlson EW et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arc h Intern Med. 2005;165(7):742-8. https://doi.org/10.1001/archinte.165.7.742
  27. Puig JG, Martinez MA, Mora M et al. Serum urate, meabolic syndromk factors: a population-based study. Nucl-eosides Nucleotides Nucleic Acids. 2008;47(6):1567-70.
  28. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriol-opathy in rats by a blood pressure-independent mecha-nism. Am J Physiol Renal Physiol. 2002;282(6):F991-7. https://doi.org/10.1152/ajprenal.00283.2001
  29. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67():1739-42. https://doi.org/10.1111/j.1523-1755.2005.00273.x
  30. Mazzali M, Hughes J, Kim YG et al. Elvated uric acid increases blood pres-sure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38():1101-6. https://doi.org/10.1161/hy1101.092839
  31. Sanchez-Lozada LG, Tapia E, Santamaria J et al. Mild hyper-uricemia induces vasoconstriction and maintains glomer-ular hypertension in nomal and remnant rats. Kidney Int. 2005;67(5):237-47. https://doi.org/10.1111/j.1523-1755.2005.00074.x
  32. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis. 1998;57(9):509-10. https://doi.org/10.1136/ard.57.9.509
  33. Keenan RT, O'Brien WR, Lee KH et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011; 124(2):155-63. https://doi.org/10.1016/j.amjmed.2010.09.012
  34. Rho YH, Choi SJ, Lee YH et al. Prevalence of the metabolic syndrome in patients with gout. J Korean Rheum Assoc. 2004;11(6):349-57.